Free Trial
→ Trump Makes Major Crypto Announcement (From Crypto 101 Media) (Ad) Buy CFLT Stock  Free CFLT Stock Alerts

Confluent (CFLT) Financials

Confluent logo
$21.51 -0.14 (-0.65%)
As of 04:00 PM Eastern
Compare
Annual Income Statements for Confluent

Annual Income Statements for Confluent

This table shows Confluent's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -95 -230 -343 -453 -443 -345
Consolidated Net Income / (Loss)		 -95 -230 -343 -453 -443 -345
Net Income / (Loss) Continuing Operations		 -95 -230 -343 -453 -443 -345
Total Pre-Tax Income 		-95 -230 -340 -446 -407 -335
Total Operating Income		 -98 -233 -340 -463 -479 -419
Total Gross Profit		 100 161 251 384 547 706
Total Revenue		 150 237 388 586 777 964
Operating Revenue		 150 237 388 586 777 964
Total Cost of Revenue		 49 75 137 202 230 257
Operating Cost of Revenue		 49 75 137 202 230 257
Total Operating Expenses		 199 394 590 846 1,026 1,125
Selling, General & Admin Expense		 25 123 109 126 138 157
Marketing Expense		 116 166 319 456 505 547
Research & Development Expense		 58 105 162 264 349 421
Restructuring Charge		 - - 0.00 0.00 35 0.00
Total Other Income / (Expense), net		 3.06 3.14 -0.01 16 72 84
Interest & Investment Income		 2.49 0.00 0.00 0.00 0.00 0.00
Other Income / (Expense), net		 0.57 3.14 -0.01 16 72 84
Income Tax Expense		 -0.01 -0.21 3.17 6.29 36 10
Basic Earnings per Share		 ($0.99) ($2.21) ($1.82) ($1.62) ($1.47) ($1.07)
Weighted Average Basic Shares Outstanding		 96.07M 104.22M 188.63M 280.08M 300.73M 321.86M
Diluted Earnings per Share		 ($0.99) ($2.21) ($1.82) ($1.62) ($1.47) ($1.07)
Weighted Average Diluted Shares Outstanding		 96.07M 104.22M 188.63M 280.08M 300.73M 321.86M
Weighted Average Basic & Diluted Shares Outstanding		 96.07M 104.22M 188.63M 291.13M 312.62M 334.02M

Quarterly Income Statements for Confluent

This table shows Confluent's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders		 -116 -106 -153 -103 -93 -94 -93 -90 -74 -88
Consolidated Net Income / (Loss)		 -116 -106 -153 -103 -93 -94 -93 -90 -74 -88
Net Income / (Loss) Continuing Operations		 -116 -106 -153 -103 -93 -94 -93 -90 -74 -88
Total Pre-Tax Income 		-114 -104 -151 -102 -91 -63 -91 -86 -71 -86
Total Operating Income		 -119 -115 -166 -119 -109 -85 -111 -108 -94 -106
Total Gross Profit		 99 115 116 131 144 156 156 170 186 194
Total Revenue		 152 169 174 189 200 213 217 235 250 261
Operating Revenue		 152 169 174 189 200 213 217 235 250 261
Total Cost of Revenue		 53 54 58 58 57 57 61 65 64 68
Operating Cost of Revenue		 53 54 58 58 57 57 61 65 64 68
Total Operating Expenses		 217 230 282 251 252 241 267 278 280 299
Selling, General & Admin Expense		 33 35 35 36 32 34 38 39 39 39
Marketing Expense		 114 123 129 128 129 120 131 133 138 145
Research & Development Expense		 70 72 85 86 91 87 98 106 103 115
Total Other Income / (Expense), net		 4.72 11 15 18 18 22 21 22 22 19
Other Income / (Expense), net		 4.72 11 15 18 18 22 21 22 22 19
Income Tax Expense		 1.87 2.23 1.65 1.67 1.57 31 2.47 3.40 2.98 1.56
Basic Earnings per Share		 ($0.41) ($0.38) ($0.52) ($0.35) ($0.30) ($0.30) ($0.30) ($0.28) ($0.23) ($0.26)
Weighted Average Basic Shares Outstanding		 282.27M 280.08M 291.86M 297.83M 303.90M 300.73M 314.20M 319.42M 324.32M 321.86M
Diluted Earnings per Share		 ($0.41) ($0.38) ($0.52) ($0.35) ($0.30) ($0.30) ($0.30) ($0.28) ($0.23) ($0.26)
Weighted Average Diluted Shares Outstanding		 282.27M 280.08M 291.86M 297.83M 303.90M 300.73M 314.20M 319.42M 324.32M 321.86M
Weighted Average Basic & Diluted Shares Outstanding		 286.40M 291.13M 296.13M 302.42M 307.88M 312.62M 317.83M 322.72M 327.99M 334.02M

Annual Cash Flow Statements for Confluent

This table details how cash moves in and out of Confluent's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 -20 18 1,339 -941 -86 36
Net Cash From Operating Activities		 -69 -82 -105 -157 -104 33
Net Cash From Continuing Operating Activities		 -29 -82 -105 -157 -104 33
Net Income / (Loss) Continuing Operations		 -95 -230 -343 -453 -443 -345
Consolidated Net Income / (Loss)		 -95 -230 -343 -453 -443 -345
Depreciation Expense		 1.20 1.57 3.63 7.62 14 22
Amortization Expense		 8.08 17 29 32 7.20 20
Non-Cash Adjustments To Reconcile Net Income		 19 156 182 288 372 403
Changes in Operating Assets and Liabilities, net		 37 -27 23 -32 -54 -67
Net Cash From Investing Activities		 36 -177 -401 -866 -85 -75
Net Cash From Continuing Investing Activities		 36 -177 -401 -866 -85 -75
Purchase of Property, Plant & Equipment		 -2.93 -4.65 -8.94 -14 -21 -24
Acquisitions		 - - 0.00 0.00 -56 -116
Purchase of Investments		 -66 -330 -664 -2,052 -1,587 -1,542
Sale and/or Maturity of Investments		 104 157 272 1,201 1,578 1,606
Net Cash From Financing Activities		 13 277 1,845 82 102 80
Net Cash From Continuing Financing Activities		 13 277 1,845 82 102 80
Repayment of Debt		 - 0.00 - -0.79 0.00 0.00
Repurchase of Common Equity		 0.00 -0.11 -3.61 -0.79 -0.26 0.00
Issuance of Common Equity		 8.97 4.77 806 41 29 24
Other Financing Activities, net		 4.47 12 -39 42 74 56
Effect of Exchange Rate Changes		 -0.09 -0.01 0.01 -0.00 0.12 -2.07
Cash Income Taxes Paid		 0.44 0.96 2.17 5.53 8.05 12

Quarterly Cash Flow Statements for Confluent

This table details how cash moves in and out of Confluent's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents		 -26 -68 -92 -31 4.40 33 -13 -25 11 63
Net Cash From Operating Activities		 -42 -27 -78 -29 -9.06 12 -26 8.59 16 35
Net Cash From Continuing Operating Activities		 -42 -27 -78 -29 -9.06 12 -26 8.59 16 35
Net Income / (Loss) Continuing Operations		 -116 -106 -153 -103 -93 -94 -93 -90 -74 -88
Consolidated Net Income / (Loss)		 -116 -106 -153 -103 -93 -94 -93 -90 -74 -88
Depreciation Expense		 2.08 2.49 3.12 3.26 3.61 3.92 4.31 5.84 5.70 6.23
Amortization Expense		 14 -1.40 2.29 1.42 1.58 1.91 3.32 4.42 5.62 6.97
Non-Cash Adjustments To Reconcile Net Income		 71 85 96 94 93 89 97 100 100 106
Changes in Operating Assets and Liabilities, net		 -13 -7.38 -27 -24 -14 12 -38 -12 -21 4.29
Net Cash From Investing Activities		 -13 -50 -52 -29 -12 8.09 -17 -47 -22 10
Net Cash From Continuing Investing Activities		 -13 -50 -52 -29 -12 8.09 -17 -47 -22 10
Purchase of Property, Plant & Equipment		 -3.83 -3.79 -5.10 -6.14 -4.02 -5.42 -5.73 -5.88 -6.28 -6.09
Purchase of Investments		 -356 -529 -453 -546 -236 -351 -443 -457 -274 -367
Sale and/or Maturity of Investments		 347 483 452 524 228 375 432 416 374 384
Net Cash From Financing Activities		 28 8.25 38 27 26 11 30 13 17 20
Net Cash From Continuing Financing Activities		 27 8.67 38 27 26 11 30 13 17 20
Other Financing Activities, net		 9.75 8.33 21 28 15 11 14 13 8.84 20
Effect of Exchange Rate Changes		 0.02 0.00 0.21 -0.31 -1.20 1.42 -0.67 -0.20 0.39 -1.59
Cash Income Taxes Paid		 1.51 1.80 1.88 2.10 2.38 1.70 1.81 3.33 4.09 2.47

Annual Balance Sheets for Confluent

This table presents Confluent's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Total Assets		 526 2,343 2,345 2,461 2,695
Total Current Assets		 428 2,226 2,198 2,252 2,351
Cash & Equivalents		 37 1,376 436 350 386
Short-Term Investments		 252 640 1,491 1,551 1,525
Accounts Receivable		 106 137 178 230 314
Prepaid Expenses		 19 45 57 77 79
Other Current Assets		 14 28 36 44 47
Plant, Property, & Equipment, net		 6.72 14 29 54 79
Total Noncurrent Assets		 92 102 118 155 265
Goodwill		 - - 0.00 52 164
Intangible Assets		 - - - 3.49 7.92
Other Noncurrent Operating Assets		 92 102 118 100 93
Total Liabilities & Shareholders' Equity		 526 2,343 2,345 2,461 2,695
Total Liabilities		 258 1,492 1,575 1,650 1,734
Total Current Liabilities		 194 348 424 487 589
Accounts Payable		 1.65 7.59 21 6.71 7.53
Accrued Expenses		 34 99 105 142 194
Current Deferred Revenue		 143 221 290 331 379
Other Current Liabilities		 16 21 7.38 7.89 8.69
Total Noncurrent Liabilities		 64 1,144 1,151 1,163 1,144
Long-Term Debt		 - 1,081 1,085 1,088 1,092
Noncurrent Deferred Revenue		 16 26 33 22 30
Other Noncurrent Operating Liabilities		 48 38 34 53 22
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -306 850 769 810 961
Total Preferred & Common Equity		 -306 850 769 810 961
Preferred Stock		 0.00 - 0.00 0.00 0.00
Total Common Equity		 -306 850 769 810 961
Common Stock		 100 1,600 1,980 2,453 2,953
Retained Earnings		 -406 -749 -1,201 -1,644 -1,989
Accumulated Other Comprehensive Income / (Loss)		 0.23 -0.83 -9.46 1.27 -2.64

Quarterly Balance Sheets for Confluent

This table presents Confluent's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets		 2,314 2,293 2,328 2,362 2,440 2,528 2,608
Total Current Assets		 2,175 2,115 2,140 2,168 2,226 2,307 2,266
Cash & Equivalents		 503 343 313 317 336 311 323
Short-Term Investments		 1,436 1,506 1,535 1,556 1,571 1,620 1,537
Accounts Receivable		 143 170 189 183 200 257 279
Prepaid Expenses		 59 59 64 71 76 74 83
Other Current Assets		 33 37 39 41 43 44 45
Plant, Property, & Equipment, net		 26 35 44 48 62 67 73
Total Noncurrent Assets		 113 142 144 146 152 154 269
Goodwill		 - 46 46 46 55 54 164
Intangible Assets		 - - - - - - 8.70
Other Noncurrent Operating Assets		 113 96 99 100 97 100 96
Total Liabilities & Shareholders' Equity		 2,314 2,293 2,328 2,362 2,440 2,528 2,608
Total Liabilities		 1,530 1,548 1,566 1,573 1,594 1,655 1,674
Total Current Liabilities		 379 401 423 435 439 520 535
Accounts Payable		 14 10 2.46 1.99 1.88 14 16
Accrued Expenses		 94 88 112 125 97 167 159
Current Deferred Revenue		 259 296 301 301 331 329 350
Other Current Liabilities		 11 7.30 7.62 7.74 10 11 11
Total Noncurrent Liabilities		 1,151 1,147 1,143 1,137 1,155 1,134 1,139
Long-Term Debt		 1,084 1,085 1,086 1,087 1,089 1,090 1,091
Noncurrent Deferred Revenue		 31 29 27 23 17 20 25
Other Noncurrent Operating Liabilities		 36 32 29 27 49 25 23
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 784 745 761 789 845 874 934
Total Preferred & Common Equity		 784 745 761 789 845 874 934
Preferred Stock		 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 784 745 761 789 845 874 934
Common Stock		 1,892 2,103 2,229 2,349 2,585 2,703 2,826
Retained Earnings		 -1,096 -1,354 -1,457 -1,550 -1,737 -1,827 -1,901
Accumulated Other Comprehensive Income / (Loss)		 -13 -4.45 -9.81 -9.77 -2.33 -2.10 9.42

Annual Metrics and Ratios for Confluent

This table displays calculated financial ratios and metrics derived from Confluent's official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 57.92% 63.95% 51.07% 32.60% 24.03%
EBITDA Growth		 0.00% -139.23% -45.32% -32.44% 5.12% 24.20%
EBIT Growth		 0.00% -135.83% -47.64% -31.40% 8.87% 17.71%
NOPAT Growth		 0.00% -137.67% -45.65% -36.23% -3.48% 12.45%
Net Income Growth		 0.00% -141.82% -49.16% -32.02% 2.17% 22.06%
EPS Growth		 0.00% -123.23% 17.65% 10.99% 9.26% 27.21%
Operating Cash Flow Growth		 0.00% -19.21% -28.03% -49.76% 34.12% 132.28%
Free Cash Flow Firm Growth		 0.00% 0.00% -20.83% -94.41% -20.80% -7.96%
Invested Capital Growth		 0.00% 0.00% -321.80% 14.33% 97.20% 7,093.73%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 9.07% 6.08% 5.25%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% -0.23% 10.55% -5.87%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 1.87% 9.11% -7.58%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% -0.28% 5.95% -5.30%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 1.86% 2.59% 1.72%
EPS Q/Q Growth		 0.00% 0.00% 0.00% -5.19% 5.16% 3.60%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -3.43% -2.08% 27.50% 219.15%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 6.08% 0.63%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% -0.79% -156.50% -13.97%
Profitability Metrics		 - - - - - -
Gross Margin		 67.04% 68.10% 64.60% 65.45% 70.44% 73.28%
EBITDA Margin		 -58.92% -89.25% -79.11% -69.36% -49.63% -30.33%
Operating Margin		 -65.49% -98.56% -87.56% -78.96% -61.62% -43.50%
EBIT Margin		 -65.11% -97.23% -87.56% -76.16% -52.34% -34.73%
Profit (Net Income) Margin		 -63.44% -97.15% -88.38% -77.23% -56.99% -35.81%
Tax Burden Percent		 99.99% 99.91% 100.93% 101.41% 108.87% 103.11%
Interest Burden Percent		 97.44% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -416.85%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% -410.52%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 377.90%
Return on Equity (ROE)		 0.00% -85.63% -61.29% -55.88% -56.05% -38.95%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -306.88%
Operating Return on Assets (OROA)		 0.00% -43.72% -23.68% -19.04% -16.92% -12.98%
Return on Assets (ROA)		 0.00% -43.68% -23.90% -19.31% -18.43% -13.39%
Return on Common Equity (ROCE)		 0.00% 97.72% -29.81% -55.88% -56.05% -38.95%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 75.05% -40.32% -58.81% -54.63% -35.90%
Net Operating Profit after Tax (NOPAT)		 -69 -163 -238 -324 -335 -293
NOPAT Margin		 -45.84% -68.99% -61.29% -55.27% -43.14% -30.45%
Net Nonoperating Expense Percent (NNEP)		 0.00% -46.17% -17.17% -14.48% -13.01% -6.34%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -17.47% -17.65% -14.29%
Cost of Revenue to Revenue		 32.96% 31.90% 35.40% 34.55% 29.56% 26.72%
SG&A Expenses to Revenue		 16.46% 51.79% 28.09% 21.45% 17.70% 16.26%
R&D to Revenue		 38.78% 44.55% 41.75% 45.06% 44.89% 43.71%
Operating Expenses to Revenue		 132.54% 166.66% 152.16% 144.42% 132.06% 116.78%
Earnings before Interest and Taxes (EBIT)		 -98 -230 -340 -446 -407 -335
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -88 -211 -307 -406 -386 -292
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 23.71 8.28 8.89 9.54
Price to Tangible Book Value (P/TBV)		 0.00 0.00 23.71 8.28 9.54 11.62
Price to Revenue (P/Rev)		 5.53 3.50 51.99 10.87 9.27 9.52
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 58.48
Enterprise Value to Revenue (EV/Rev)		 0.00 4.71 49.57 9.43 8.23 8.67
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 249.62
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 0.00 0.00 1.27 1.41 1.34 1.14
Long-Term Debt to Equity		 0.00 0.00 1.27 1.41 1.34 1.14
Financial Leverage		 0.00 -1.08 -1.09 -1.10 -1.05 -0.92
Leverage Ratio		 0.00 1.96 2.56 2.89 3.04 2.91
Compound Leverage Factor		 0.00 1.96 2.56 2.89 3.04 2.91
Debt to Total Capital		 0.00% 0.00% 55.97% 58.50% 57.32% 53.19%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 55.97% 58.50% 57.32% 53.19%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 214.11% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% -114.11% 44.03% 41.50% 42.68% 46.81%
Debt to EBITDA		 0.00 0.00 -3.52 -2.67 -2.82 -3.74
Net Debt to EBITDA		 0.00 0.00 3.05 2.07 2.11 2.80
Long-Term Debt to EBITDA		 0.00 0.00 -3.52 -2.67 -2.82 -3.74
Debt to NOPAT		 0.00 0.00 -4.55 -3.35 -3.25 -3.72
Net Debt to NOPAT		 0.00 0.00 3.93 2.60 2.42 2.79
Long-Term Debt to NOPAT		 0.00 0.00 -4.55 -3.35 -3.25 -3.72
Altman Z-Score		 0.00 0.39 8.31 2.24 2.31 2.87
Noncontrolling Interest Sharing Ratio		 0.00% 214.11% 51.37% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - -
Current Ratio		 0.00 2.21 6.39 5.18 4.62 3.99
Quick Ratio		 0.00 2.04 6.18 4.96 4.38 3.78
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -143 -173 -336 -406 -438
Operating Cash Flow to CapEx		 -2,350.09% -1,764.67% -1,174.90% -1,088.43% -501.27% 139.59%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.00 0.45 0.27 0.25 0.32 0.37
Accounts Receivable Turnover		 0.00 2.23 3.19 3.71 3.81 3.54
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 35.22 36.68 26.93 18.70 14.52
Accounts Payable Turnover		 0.00 45.85 29.73 13.95 16.32 36.15
Days Sales Outstanding (DSO)		 0.00 163.50 114.56 98.32 95.87 103.08
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 7.96 12.28 26.17 22.37 10.10
Cash Conversion Cycle (CCC)		 0.00 155.54 102.28 72.15 73.50 92.98
Capital & Investment Metrics		 - - - - - -
Invested Capital		 0.00 -20 -85 -73 -2.04 143
Invested Capital Turnover		 0.00 -23.47 -7.37 -7.42 -20.75 13.69
Increase / (Decrease) in Invested Capital		 0.00 -20 -65 12 71 145
Enterprise Value (EV)		 0.00 1,114 19,228 5,527 6,392 8,352
Market Capitalization		 828 828 20,164 6,370 7,204 9,171
Book Value per Share		 $0.00 ($2.94) $3.22 $2.69 $2.63 $2.93
Tangible Book Value per Share		 $0.00 ($2.94) $3.22 $2.69 $2.45 $2.41
Total Capital		 0.00 268 1,931 1,854 1,899 2,053
Total Debt		 0.00 0.00 1,081 1,085 1,088 1,092
Total Long-Term Debt		 0.00 0.00 1,081 1,085 1,088 1,092
Net Debt		 0.00 -289 -935 -842 -812 -818
Capital Expenditures (CapEx)		 2.93 4.65 8.94 14 21 24
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -55 -138 -153 -136 -148
Debt-free Net Working Capital (DFNWC)		 0.00 234 1,878 1,774 1,765 1,762
Net Working Capital (NWC)		 0.00 234 1,878 1,774 1,765 1,762
Net Nonoperating Expense (NNE)		 26 67 105 129 108 52
Net Nonoperating Obligations (NNO)		 0.00 -289 -935 -842 -812 -818
Total Depreciation and Amortization (D&A)		 9.28 19 33 40 21 42
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -23.10% -35.61% -26.12% -17.52% -15.41%
Debt-free Net Working Capital to Revenue		 0.00% 98.87% 484.16% 302.72% 227.12% 182.86%
Net Working Capital to Revenue		 0.00% 98.87% 484.16% 302.72% 227.12% 182.86%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($1.82) ($1.62) ($1.47) ($1.07)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 272.95M 280.08M 300.73M 321.86M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($1.82) ($1.62) ($1.47) ($1.07)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 272.95M 280.08M 300.73M 321.86M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($1.82) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 188.63M 291.13M 312.62M 334.02M
Normalized Net Operating Profit after Tax (NOPAT)		 -69 -163 -238 -324 -311 -293
Normalized NOPAT Margin		 -45.84% -68.99% -61.29% -55.27% -40.00% -30.45%
Pre Tax Income Margin		 -63.45% -97.23% -87.56% -76.16% -52.34% -34.73%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -0.05% -1.05% -0.17% -0.06% 0.00%

Quarterly Metrics and Ratios for Confluent

This table displays calculated financial ratios and metrics derived from Confluent's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 47.93% 40.64% 38.18% 35.78% 31.93% 26.39% 24.63% 24.14% 24.99% 22.53%
EBITDA Growth		 -12.48% -0.90% -44.15% 7.46% 12.32% 44.35% 43.04% 21.47% 30.34% -28.41%
EBIT Growth		 -19.84% 7.60% -34.38% 12.37% 20.21% 39.31% 40.03% 15.00% 21.88% -37.50%
NOPAT Growth		 -25.49% -1.15% -48.99% -1.76% 8.64% 26.36% 32.96% 9.23% 13.78% -24.92%
Net Income Growth		 -21.31% 7.48% -35.02% 12.08% 20.15% 11.13% 39.06% 13.08% 19.99% 6.42%
EPS Growth		 -10.81% -26.67% -26.83% 16.67% 26.83% 21.05% 42.31% 20.00% 23.33% 13.33%
Operating Cash Flow Growth		 -131.58% -13.41% -41.32% 13.18% 78.30% 145.18% 66.63% 129.56% 272.33% 187.79%
Free Cash Flow Firm Growth		 -984.36% 0.00% -3,221.99% -267.37% -114.75% -40.36% 26.29% 33.05% -50.04% -68.28%
Invested Capital Growth		 -20.87% 14.33% 73.18% 100.28% 105.00% 97.20% 240.70% 14,855.45% 4,493.47% 7,093.73%
Revenue Q/Q Growth		 8.84% 11.16% 3.34% 8.60% 5.76% 6.50% 1.90% 8.17% 6.47% 4.40%
EBITDA Q/Q Growth		 6.61% -4.68% -41.85% 33.27% 11.51% 33.56% -45.20% 8.00% 21.50% -22.46%
EBIT Q/Q Growth		 1.67% 9.22% -45.58% 32.57% 10.47% 30.95% -43.87% 4.43% 17.72% -21.54%
NOPAT Q/Q Growth		 -1.36% 3.29% -44.45% 28.13% 8.99% 22.05% -31.50% 2.70% 13.55% -12.94%
Net Income Q/Q Growth		 1.34% 8.76% -44.08% 32.20% 10.40% -1.54% 1.20% 3.30% 17.53% -18.76%
EPS Q/Q Growth		 2.38% 7.32% -36.84% 32.69% 14.29% 0.00% 0.00% 6.67% 17.86% -13.04%
Operating Cash Flow Q/Q Growth		 -24.74% 35.15% -187.21% 62.63% 68.82% 235.04% -312.13% 133.10% 81.76% 125.52%
Free Cash Flow Firm Q/Q Growth		 -60.35% -30.99% -83.04% 4.44% 6.27% 14.38% 3.88% 13.20% -110.05% 3.97%
Invested Capital Q/Q Growth		 7.71% -0.79% 73.15% 101.12% 1,542.73% -156.50% 1,447.89% 19.54% 404.55% -13.97%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 64.95% 68.01% 66.64% 69.40% 71.75% 73.24% 71.82% 72.35% 74.54% 74.13%
EBITDA Margin		 -64.57% -60.81% -83.47% -51.29% -42.92% -26.77% -38.15% -32.44% -23.92% -28.06%
Operating Margin		 -78.36% -68.17% -95.29% -63.06% -54.27% -39.72% -51.26% -46.11% -37.44% -40.50%
EBIT Margin		 -75.25% -61.46% -86.58% -53.76% -45.51% -29.51% -41.66% -36.81% -28.44% -33.11%
Profit (Net Income) Margin		 -76.48% -62.78% -87.52% -54.64% -46.29% -44.14% -42.80% -38.26% -29.63% -33.71%
Tax Burden Percent		 101.64% 102.15% 101.09% 101.64% 101.72% 149.58% 102.72% 103.94% 104.18% 101.80%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -7,389.59% -1,686.96% -282.90% -388.10%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -7,387.69% -1,685.21% -281.80% -386.39%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7,350.70% 1,651.07% 254.06% 355.68%
Return on Equity (ROE)		 -52.55% -55.88% -62.26% -61.35% -57.79% -56.05% -38.89% -35.89% -28.84% -32.42%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% -200,946.00% -11,960.39% 0.00% -1,249.48% -1,943.06% -520.01% -306.88%
Operating Return on Assets (OROA)		 -22.31% -15.36% -23.82% -15.81% -14.26% -9.54% -14.44% -13.12% -10.48% -12.38%
Return on Assets (ROA)		 -22.68% -15.69% -24.08% -16.07% -14.50% -14.27% -14.83% -13.64% -10.92% -12.60%
Return on Common Equity (ROCE)		 -52.55% -55.88% -62.26% -61.35% -57.79% -56.05% -38.89% -35.89% -28.84% -32.42%
Return on Equity Simple (ROE_SIMPLE)		 -58.82% 0.00% -66.07% -62.77% -57.60% 0.00% -45.33% -42.30% -37.58% 0.00%
Net Operating Profit after Tax (NOPAT)		 -83 -80 -116 -84 -76 -59 -78 -76 -66 -74
NOPAT Margin		 -54.85% -47.72% -66.70% -44.14% -37.99% -27.81% -35.88% -32.28% -26.20% -28.35%
Net Nonoperating Expense Percent (NNEP)		 -3.48% -2.86% -4.34% -2.43% -2.03% -4.21% -1.90% -1.75% -1.10% -1.72%
Return On Investment Capital (ROIC_SIMPLE)		 - -4.34% - - - -3.12% - - - -3.61%
Cost of Revenue to Revenue		 35.05% 31.99% 33.36% 30.60% 28.25% 26.76% 28.18% 27.65% 25.46% 25.87%
SG&A Expenses to Revenue		 21.78% 20.88% 20.28% 19.20% 15.92% 15.92% 17.70% 16.78% 15.78% 15.07%
R&D to Revenue		 46.20% 42.57% 48.70% 45.26% 45.58% 40.79% 44.91% 45.13% 41.06% 43.98%
Operating Expenses to Revenue		 143.31% 136.19% 161.93% 132.46% 126.02% 112.96% 123.08% 118.46% 111.97% 114.63%
Earnings before Interest and Taxes (EBIT)		 -114 -104 -151 -102 -91 -63 -91 -86 -71 -86
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -98 -103 -145 -97 -86 -57 -83 -76 -60 -73
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 8.55 8.28 9.41 13.73 11.35 8.89 11.12 10.74 7.04 9.54
Price to Tangible Book Value (P/TBV)		 8.55 8.28 10.03 14.61 12.05 9.54 11.89 11.45 8.64 11.62
Price to Revenue (P/Rev)		 12.48 10.87 11.05 15.29 12.23 9.27 11.46 10.84 7.18 9.52
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 44,069.34 2,260.45 0.00 311.68 259.70 34.99 58.48
Enterprise Value to Revenue (EV/Rev)		 10.88 9.43 9.85 14.17 11.15 8.23 10.46 9.87 6.34 8.67
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 554.06 249.62
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 1.38 1.41 1.46 1.43 1.38 1.34 1.29 1.25 1.17 1.14
Long-Term Debt to Equity		 1.38 1.41 1.46 1.43 1.38 1.34 1.29 1.25 1.17 1.14
Financial Leverage		 -1.08 -1.10 -1.06 -1.05 -1.04 -1.05 -1.00 -0.98 -0.90 -0.92
Leverage Ratio		 2.06 2.89 2.92 2.99 2.97 3.04 2.98 2.97 2.88 2.91
Compound Leverage Factor		 2.06 2.89 2.92 2.99 2.97 3.04 2.98 2.97 2.88 2.91
Debt to Total Capital		 58.02% 58.50% 59.30% 58.79% 57.95% 57.32% 56.31% 55.51% 53.87% 53.19%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 58.02% 58.50% 59.30% 58.79% 57.95% 57.32% 56.31% 55.51% 53.87% 53.19%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 41.98% 41.50% 40.70% 41.21% 42.05% 42.68% 43.69% 44.49% 46.13% 46.81%
Debt to EBITDA		 -2.67 -2.67 -2.41 -2.45 -2.52 -2.82 -3.37 -3.61 -3.95 -3.74
Net Debt to EBITDA		 2.11 2.07 1.70 1.72 1.82 2.11 2.53 2.78 2.78 2.80
Long-Term Debt to EBITDA		 -2.67 -2.67 -2.41 -2.45 -2.52 -2.82 -3.37 -3.61 -3.95 -3.74
Debt to NOPAT		 -3.36 -3.35 -3.00 -2.99 -3.05 -3.25 -3.67 -3.77 -3.92 -3.72
Net Debt to NOPAT		 2.65 2.60 2.11 2.09 2.20 2.42 2.75 2.91 2.76 2.79
Long-Term Debt to NOPAT		 -3.36 -3.35 -3.00 -2.99 -3.05 -3.25 -3.67 -3.77 -3.92 -3.72
Altman Z-Score		 2.97 2.72 2.85 4.16 3.56 2.78 3.63 3.47 2.39 3.18
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 5.74 5.18 5.27 5.05 4.98 4.62 5.07 4.44 4.24 3.99
Quick Ratio		 5.50 4.96 5.03 4.81 4.72 4.38 4.80 4.21 4.00 3.78
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -71 -93 -170 -162 -152 -130 -125 -109 -228 -219
Operating Cash Flow to CapEx		 -1,089.56% -715.03% -1,524.34% -473.37% -225.21% 225.95% -453.35% 146.06% 248.77% 578.27%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.30 0.25 0.28 0.29 0.31 0.32 0.35 0.36 0.37 0.37
Accounts Receivable Turnover		 4.15 3.71 4.31 4.05 4.49 3.81 4.44 3.88 3.96 3.54
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 28.62 26.93 23.51 20.91 19.90 18.70 16.89 15.68 15.12 14.52
Accounts Payable Turnover		 22.15 13.95 23.10 24.82 27.91 16.32 37.76 29.16 28.21 36.15
Days Sales Outstanding (DSO)		 88.00 98.32 84.66 90.21 81.29 95.87 82.25 94.07 92.06 103.08
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 16.48 26.17 15.80 14.71 13.08 22.37 9.67 12.52 12.94 10.10
Cash Conversion Cycle (CCC)		 71.52 72.15 68.86 75.50 68.21 73.50 72.58 81.56 79.12 92.98
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 -72 -73 -20 0.22 3.61 -2.04 28 33 166 143
Invested Capital Turnover		 -8.13 -7.42 -13.71 -17.52 -21.33 -20.75 205.95 52.27 10.80 13.69
Increase / (Decrease) in Invested Capital		 -12 12 53 79 76 71 47 33 162 145
Enterprise Value (EV)		 5,846 5,527 6,243 9,695 8,169 6,392 8,579 8,545 5,809 8,352
Market Capitalization		 6,702 6,370 7,007 10,456 8,955 7,204 9,396 9,386 6,577 9,171
Book Value per Share		 $2.78 $2.69 $2.56 $2.57 $2.61 $2.63 $2.69 $2.75 $2.90 $2.93
Tangible Book Value per Share		 $2.78 $2.69 $2.40 $2.42 $2.46 $2.45 $2.52 $2.58 $2.36 $2.41
Total Capital		 1,867 1,854 1,830 1,848 1,876 1,899 1,934 1,964 2,026 2,053
Total Debt		 1,084 1,085 1,085 1,086 1,087 1,088 1,089 1,090 1,091 1,092
Total Long-Term Debt		 1,084 1,085 1,085 1,086 1,087 1,088 1,089 1,090 1,091 1,092
Net Debt		 -856 -842 -764 -761 -785 -812 -818 -841 -768 -818
Capital Expenditures (CapEx)		 3.83 3.79 5.10 6.14 4.02 5.42 5.73 5.88 6.28 6.09
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -144 -153 -136 -131 -140 -136 -120 -144 -128 -148
Debt-free Net Working Capital (DFNWC)		 1,796 1,774 1,714 1,716 1,733 1,765 1,787 1,787 1,731 1,762
Net Working Capital (NWC)		 1,796 1,774 1,714 1,716 1,733 1,765 1,787 1,787 1,731 1,762
Net Nonoperating Expense (NNE)		 33 25 36 20 17 35 15 14 8.58 14
Net Nonoperating Obligations (NNO)		 -856 -842 -764 -761 -785 -812 -818 -841 -768 -818
Total Depreciation and Amortization (D&A)		 16 1.09 5.41 4.67 5.19 5.83 7.63 10 11 13
Debt-free, Cash-free Net Working Capital to Revenue		 -26.77% -26.12% -21.44% -19.19% -19.14% -17.52% -14.64% -16.65% -14.01% -15.41%
Debt-free Net Working Capital to Revenue		 334.31% 302.72% 270.28% 250.93% 236.55% 227.12% 217.95% 206.45% 189.08% 182.86%
Net Working Capital to Revenue		 334.31% 302.72% 270.28% 250.93% 236.55% 227.12% 217.95% 206.45% 189.08% 182.86%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.41) ($0.38) ($0.52) ($0.35) ($0.30) ($0.30) ($0.30) ($0.28) ($0.23) ($0.26)
Adjusted Weighted Average Basic Shares Outstanding		 282.27M 280.08M 291.86M 297.83M 303.90M 300.73M 314.20M 319.42M 324.32M 321.86M
Adjusted Diluted Earnings per Share		 ($0.41) ($0.38) ($0.52) ($0.35) ($0.30) ($0.30) ($0.30) ($0.28) ($0.23) ($0.26)
Adjusted Weighted Average Diluted Shares Outstanding		 282.27M 280.08M 291.86M 297.83M 303.90M 300.73M 314.20M 319.42M 324.32M 321.86M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 286.40M 291.13M 296.13M 302.42M 307.88M 312.62M 317.83M 322.72M 327.99M 334.02M
Normalized Net Operating Profit after Tax (NOPAT)		 -83 -80 -93 -83 -76 -59 -78 -76 -66 -74
Normalized NOPAT Margin		 -54.85% -47.72% -53.30% -43.80% -37.80% -27.81% -35.88% -32.28% -26.20% -28.35%
Pre Tax Income Margin		 -75.25% -61.46% -86.58% -53.76% -45.51% -29.51% -41.66% -36.81% -28.44% -33.11%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.26% -0.17% 0.00% 0.00% -0.07% -0.06% 0.00% -0.01% 0.00% 0.00%

Frequently Asked Questions About Confluent's Financials

When does Confluent's fiscal year end?

According to the most recent income statement we have on file, Confluent's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Confluent's net income changed over the last 5 years?

Confluent's net income appears to be on an upward trend, with a most recent value of -$345.07 million in 2024, rising from -$95.04 million in 2019. The previous period was -$442.75 million in 2023.

What is Confluent's operating income?
Confluent's total operating income in 2024 was -$419.15 million, based on the following breakdown:
  • Total Gross Profit: $706.17 million
  • Total Operating Expenses: $1.13 billion
How has Confluent revenue changed over the last 5 years?

Over the last 5 years, Confluent's total revenue changed from $149.81 million in 2019 to $963.64 million in 2024, a change of 543.3%.

How much debt does Confluent have?

Confluent's total liabilities were at $1.73 billion at the end of 2024, a 5.0% increase from 2023, and a 572.7% increase since 2020.

How much cash does Confluent have?

In the past 4 years, Confluent's cash and equivalents has ranged from $36.79 million in 2020 to $1.38 billion in 2021, and is currently $385.98 million as of their latest financial filing in 2024.

How has Confluent's book value per share changed over the last 5 years?

Over the last 5 years, Confluent's book value per share changed from 0.00 in 2019 to 2.93 in 2024, a change of 293.1%.

Remove Ads

Related Companies

This page (NASDAQ:CFLT) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
Markets in Chaos? Here’s What to Do.
Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...
Investors Alley | Sponsored
The Last Time This Happened, Americans Lost Billions
Wall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...
Banyan Hill Publishing | Sponsored
Catastrophic
The losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.
InvestorPlace | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
The real reason gold is soaring (and likely to continue)
Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...
Golden Portfolio | Sponsored
Trump to unlock 15-figure fortune for America (May 3rd) ?
Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...
Paradigm Press | Sponsored
DOGE tax surprise
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...
Altimetry | Sponsored